Internal Medicine, Hematology & Oncology · Guaynabo, PR
NPI
1720019912
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
59 Calle Cerezo, Finca Elena
Guaynabo, PR, 00971
Phone (787) 381-5858
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,407
112 services
Medicare patients, 2024
26
Average age 74
Drug cost, 2024
$5.9M
1,078 prescriptions
Company payments, 2025
$11K
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria V Garcia Pallas was code 99214 (office e&m - established), 26 times for 13 patients. In total Maria V Garcia Pallas billed 112 services in 14 codes, and Medicare paid $8,407.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 26 | 13 | $93.70 | $2,436 |
By year: 2022 $9,159 for 1,704 services; 2023 $38K for 4,612 services; 2024 $8,407 for 112 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria V Garcia Pallas prescribed most often to Medicare patients was Sprycel (Dasatinib), with 79 prescriptions and refills. In total Maria V Garcia Pallas wrote 1,078 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sprycel Dasatinib | 79 | 79 | 11 | $1.4M |
| Anastrozole Generic | 66 | 82 | 12 | $876 |
| Venclexta Venetoclax | 48 | 48 | 12 | $447K |
| Promacta Eltrombopag Olamine | 39 | 39 | Under 11 | $727K |
| Famotidine Generic | 38 | 46 | 22 | $266 |
| Prednisone Generic | 36 | 36 | 12 | $188 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 30 | 30 | 20 | $665 |
| Dexamethasone Generic | 29 | 31 | 20 | $850 |
| Hydroxyurea Generic | 24 | 24 | Under 11 | $967 |
| Bicalutamide Generic | 21 | 21 | Under 11 | $483 |
| Ondansetron Hcl Generic | 21 | 21 | 16 | $189 |
| Metoclopramide Hcl Generic | 20 | 20 | 17 | $177 |
| Abiraterone Acetate Generic | 18 | 18 | Under 11 | $36K |
| Synthroid Levothyroxine Sodium | 17 | 17 | Under 11 | $833 |
| Calquence Acalabrutinib Maleate | 17 | 17 | Under 11 | $252K |
Brand drugs: 484 claims; generic drugs: 594 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria V Garcia Pallas $11K ($11K in general payments such as food, travel and fees) from 37 companies. The largest payer was Abbvie Inc. with $6,105.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $6,105 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $2,877 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $320 |
| Janssen Pharmaceuticals, Inc JNJ | 12 | $216 |
| Pbg Puerto Rico LLC | 11 | $168 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $130 |
| Sobi, Inc SOBI.ST | 6 | $123 |
| Genzyme Corporation SNY | 5 | $110 |
| Merck Sharp & Dohme LLC MRK | 5 | $108 |
| Tempus AI, Inc TEM | 4 | $83.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.